- Profile
- Personal Information
- Publications
Experts in Infectious Diseases
MIYAGAWA Happei Konstantina Alexandropoulos Richard J. Lamont Juhi Bagaitkar Beatriz Mothe Nikolaos G. Almyroudis José Esté Carla Renata Arciola Ioannis Androulakis Emily S Barrett Maria Casadellà David A. Scott Shuang Liang Gong Jianhua CHRIS ROMAN MATT STINSON Dr. Alla Adams Sanghamitra Dey Jonathan Claus ARMANDO PAEZ View MoreBarclay A. Buck Phillips
Senior Vice President
Chief Financial Officer and Treasurer
Novavax Inc
United States of America
Mr. Phillips joined Novavax in June 2013 as Senior Vice President and Chief Financial Officer, with responsibility for managing all of Novavax’ financial strategy, treasury and communications functions. He was most recently Senior Vice President and Chief Financial Officer of Micromet, Inc. which was acquired by Amgen in 2012. Previously, he was Managing Director of Vector Fund Management and a Biotechnology Analyst and Director of Venture Investments at Invesco Funds Group, Inc. Mr. Phillips received a Bachelor of Arts degree in economics from the University of Colorado at Boulder.
Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. Our vaccine candidates are genetically engineered three-dimensional nanostructures that incorporate recombinant proteins critical to disease pathogenesis.